Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma

Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6200

Full metadata record

DC Field	Value	Language
dc.contributor.author	Craig Wallington-Gates	en
dc.contributor.author	Lisa M. Ebert	en
dc.contributor.author	Kate Vandyke	en
dc.contributor.author	M. Zahied Johan	en
dc.contributor.author	Mark DeNichilo	en
dc.contributor.author	Lih Y. Tan	en
dc.contributor.author	Kay K. Myo Min	en
dc.contributor.author	Benjamin M. Weimann	en
dc.contributor.author	Brenton W. Ebert	en
dc.contributor.author	Stuart M. Pitson	en
dc.contributor.author	Andrew C. W. Zannettino	en
dc.contributor.author	Claudine S. Bonder	en
dc.date.accessioned	2024-08-08T03:26:11Z	-
dc.date.available	2024-08-08T03:26:11Z	-
dc.date.issued	2021	-
dc.identifier.citation	Molecular Oncology, 2021, Volume 16 (6), p.1221-1240	en
dc.identifier.uri	https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6200	-
dc.language.iso	en	en
dc.publisher	Wiley	en
dc.title	Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma	en
dc.type	Article	en
dc.identifier.doi	10.1002/1878-0261.13055	-
dc.rights.holder	Craig Wallington-Gates	en
dc.identifier.journaltitle	Molecular Oncology	-
dc.identifier.external	96818419	-
item.openairetype	Article	-
item.fulltext	No Fulltext	-
item.grantfulltext	none	-
item.languageiso639-1	en	-
item.cerifentitytype	Publications	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
Appears in Sites:	Sunshine Coast HHS Publications

98

checked on Nov 22, 2024

Check